{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T04:35:28Z","timestamp":1717734928369},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T00:00:00Z","timestamp":1429228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13062-015-0044-y","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T08:25:18Z","timestamp":1429172718000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Synthetic lethals in HIV: ways to avoid drug resistance"],"prefix":"10.1186","volume":"10","author":[{"given":"Michel","family":"Petitjean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Badel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner A","family":"Veitia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Vanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,17]]},"reference":[{"key":"44_CR1","volume-title":"The molecular and cellular biology of the yeast Saccharomyces","author":"C Kaiser","year":"1997","unstructured":"Kaiser C, Gimeno R, Shaywitz D. The molecular and cellular biology of the yeast Saccharomyces. Cold Spring Harbor, NY: Cold Spring Harbor laboratory press; 1997."},{"issue":"9","key":"44_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nmeth.1239","volume":"5","author":"G Butland","year":"2008","unstructured":"Butland G, Babu M, Diaz-Mejia JJ, Bohdana F, Phanse S, Gold B, et al. eSGA: E. coli synthetic genetic array analysis. Nat Methods. 2008;5(9):789\u201395. doi:10.1038\/nmeth.1239.","journal-title":"Nat Methods"},{"issue":"6","key":"44_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/PPO.0b013e31823e5370","volume":"17","author":"SR Kim","year":"2011","unstructured":"Kim SR, Paik S. Genomics of adjuvant therapy for breast cancer. Cancer J. 2011;17(6):500\u20134. doi:10.1097\/PPO.0b013e31823e537000130404-201111000-00012.","journal-title":"Cancer J"},{"issue":"11","key":"44_CR4","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2217\/fon.10.131","volume":"6","author":"HJ Kuiken","year":"2010","unstructured":"Kuiken HJ, Beijersbergen RL. Exploration of synthetic lethal interactions as cancer drug targets. Future Oncol. 2010;6(11):1789\u2013802. 10.2217\/fon.10.131.","journal-title":"Future Oncol"},{"issue":"4","key":"44_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/156800912800190938","volume":"12","author":"D Soncini","year":"2012","unstructured":"Soncini D, Caffa I, Patrone F, Ballestrero A, Nencioni A. Synthetic lethality-based therapeutics: perspectives for applications in colorectal cancer. Curr Cancer Drug Targets. 2012;12(4):329\u201338. doi:CCDT-EPUB-20120305-002.","journal-title":"Curr Cancer Drug Targets"},{"key":"44_CR6","doi-asserted-by":"crossref","unstructured":"Bazin C, Coupaye, R., Midendorp, S. & Vanet, A. Between compensatory mutations ans synthetic lethals: genetic mutations, a new challenge for tomorrow's medicine. Science Postprint. 2014. doi:10.14340\/spp.2014.10R0002.","DOI":"10.14340\/spp.2014.10R0002"},{"key":"44_CR7","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1745-6150-5-40","volume":"5","author":"S Brouillet","year":"2010","unstructured":"Brouillet S, Valere T, Ollivier E, Marsan L, Vanet A. Co-lethality studied as an asset against viral drug escape: the HIV protease case. Biol Direct. 2010;5:40. doi:10.1186\/1745-6150-5-40.","journal-title":"Biol Direct"},{"issue":"4","key":"44_CR8","first-page":"179","volume":"8","author":"CF Perno","year":"2006","unstructured":"Perno CF, Svicher V, Ceccherini-Silberstein F. Novel drug resistance mutations in HIV: recognition and clinical relevance. AIDS Rev. 2006;8(4):179\u201390.","journal-title":"AIDS Rev"},{"issue":"Suppl 2","key":"44_CR9","doi-asserted-by":"publisher","first-page":"S309","DOI":"10.1086\/655653","volume":"202","author":"CL Boutwell","year":"2010","unstructured":"Boutwell CL, Rolland MM, Herbeck JT, Mullins JI, Allen TM. Viral evolution and escape during acute HIV-1 infection. J Infect Dis. 2010;202 Suppl 2:S309\u201314. 10.1086\/655653.","journal-title":"J Infect Dis"},{"issue":"Suppl 8","key":"44_CR10","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1186\/1471-2105-10-S8-S10","volume":"10","author":"O Haq","year":"2009","unstructured":"Haq O, Levy RM, Morozov AV, Andrec M. Pairwise and higher-order correlations among drug-resistance mutations in HIV-1 subtype B protease. BMC Bioinformatics. 2009;10 Suppl 8:S10. doi:10.1186\/1471-2105-10-S8-S10.","journal-title":"BMC Bioinformatics"},{"issue":"24","key":"44_CR11","doi-asserted-by":"publisher","first-page":"13598","DOI":"10.1128\/JVI.01570-07","volume":"81","author":"AF Poon","year":"2007","unstructured":"Poon AF, Kosakovsky Pond SL, Richman DD, Frost SD. Mapping protease inhibitor resistance to human immunodeficiency virus type 1 sequence polymorphisms within patients. J Virol. 2007;81(24):13598\u2013607. doi:10.1128\/JVI.01570-07.","journal-title":"J Virol"},{"issue":"10","key":"44_CR12","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/bioinformatics\/btn110","volume":"24","author":"Y Liu","year":"2008","unstructured":"Liu Y, Eyal E, Bahar I. Analysis of correlated mutations in HIV-1 protease using spectral clustering. Bioinformatics. 2008;24(10):1243\u201350. doi:10.1093\/bioinformatics\/btn110.","journal-title":"Bioinformatics"},{"issue":"8","key":"44_CR13","doi-asserted-by":"publisher","first-page":"e814","DOI":"10.1371\/journal.pone.0000814","volume":"2","author":"Q Wang","year":"2007","unstructured":"Wang Q, Lee C. Distinguishing functional amino acid covariation from background linkage disequilibrium in HIV protease and reverse transcriptase. PLoS One. 2007;2(8):e814. 10.1371\/journal.pone.0000814.","journal-title":"PLoS One"},{"key":"44_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4236\/jbise.2010.33039","volume":"3","author":"D King","year":"2010","unstructured":"King D, Cherry R, Hu W. Covariation of mutation pairs expressed in HIV-1 protease and reverse transcriptase genes subjected to varying treatments. J Biomedical Science and Engineering. 2010;3:291\u20139.","journal-title":"J Biomedical Science and Engineering"},{"issue":"2","key":"44_CR15","doi-asserted-by":"publisher","first-page":"e1001301","DOI":"10.1371\/journal.pgen.1001301","volume":"7","author":"S Kryazhimskiy","year":"2011","unstructured":"Kryazhimskiy S, Dushoff J, Bazykin GA, Plotkin JB. Prevalence of epistasis in the evolution of influenza A surface proteins. PLoS Genet. 2011;7(2):e1001301. 10.1371\/journal.pgen.1001301.","journal-title":"PLoS Genet"},{"issue":"3","key":"44_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.immuni.2012.11.022","volume":"38","author":"AL Ferguson","year":"2013","unstructured":"Ferguson AL, Mann JK, Omarjee S, Ndung'u T, Walker BD, Chakraborty AK. ranslating HIV Sequences into Quantitative Fitness Landscapes Predicts Viral Vulnerabilities for Rational Immunogen Design. Immunity. 2013;38(3):606\u201317. doi:10.1016\/j.immuni.2012.11.022.","journal-title":"Immunity"},{"issue":"5","key":"44_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ng.795","volume":"43","author":"T Hinkley","year":"2011","unstructured":"Hinkley T, Martins J, Chappey C, Haddad M, Stawiski E, Whitcomb JM, et al. A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase. Nat Genet. 2011;43(5):487\u20139. doi:10.1038\/ng.795.","journal-title":"Nat Genet"},{"issue":"15","key":"44_CR18","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1073\/pnas.90.15.7176","volume":"90","author":"BT Korber","year":"1993","unstructured":"Korber BT, Farber RM, Wolpert DH, Lapedes AS. Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis. Proc Natl Acad Sci U S A. 1993;90(15):7176\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"44_CR19","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/bioinformatics\/btt724","volume":"30","author":"M Petitjean","year":"2014","unstructured":"Petitjean M, Vanet A. VIRAPOPS : A forward simulator dedicated to rapidly evolved viral population. Bioinformatics. 2014;30(4):578\u201380. 10.1093\/bioinformatics\/btt724.","journal-title":"Bioinformatics"},{"key":"44_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1751-0473-9-18","volume":"9","author":"M Petitjean","year":"2014","unstructured":"Petitjean M, Vanet A. VIRAPOPS2 supports the influenza virus reassortments. Source Code for Biology and Medicine. 2014;9:18.","journal-title":"Source Code for Biology and Medicine"},{"key":"44_CR21","unstructured":"Vanet A, Val\u00e8re T, Muller-Trutwin M, inventors; Method for identifying motifs and\/or combinations of motifs having a Boolean state of predetermined mutation in a set of sequences and its applications patent US: 7,917,303 B2. 2003 March 29, 2011."},{"key":"44_CR22","unstructured":"Vanet A, Val\u00e8re T, Muller-Trutwin M, inventors; Methods for identifying motifs and\/or combinations of motifs having a boolean state of predetermined mutation. France patent WO : 99\/61658, US,7,734,421 B2. 2010 June 8, 2010."},{"issue":"8","key":"44_CR23","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1128\/JVI.77.8.4836-4847.2003","volume":"77","author":"TD Wu","year":"2003","unstructured":"Wu TD, Schiffer CA, Gonzales MJ, Taylor J, Kantor R, Chou S, et al. Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments. J Virol. 2003;77(8):4836\u201347.","journal-title":"J Virol"},{"issue":"2","key":"44_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0042-6822(03)00484-7","volume":"31","author":"NG Hoffman","year":"2003","unstructured":"Hoffman NG, Schiffer CA, Swanstrom R. Covariation of amino acid positions in HIV-1 protease. Virology. 2003;31(2):536\u201348. doi:S0042682203004847.","journal-title":"Virology"},{"issue":"3","key":"44_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.meegid.2006.09.004","volume":"7","author":"K Deforche","year":"2007","unstructured":"Deforche K, Camacho R, Grossman Z, Silander T, Soares MA, Moreau Y, et al. Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors. Infect Genet Evol. 2007;7(3):382\u201390. doi:10.1016\/j.meegid.2006.09.004.","journal-title":"Infect Genet Evol"},{"issue":"1","key":"44_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0022-2836(84)90231-6","volume":"178","author":"TJ Richmond","year":"1984","unstructured":"Richmond TJ. Solvent accessible surface area and excluded volume in proteins. Analytical equations for overlapping spheres and implications for the hydrophobic effect. J Mol Biol. 1984;178(1):63\u201389. doi:0022-2836(84)90231-6.","journal-title":"J Mol Biol"},{"key":"44_CR27","doi-asserted-by":"publisher","first-page":"W44","DOI":"10.1093\/nar\/gki477","volume":"33(Web Server i","author":"C Alland","year":"2005","unstructured":"Alland C, Moreews F, Boens D, Carpentier M, Chiusa S, Lonquety M, et al. RPBS: a web resource for structural bioinformatics. Nucleic Acids Res. 2005;33(Web Server issue):W44\u20139. doi:10.1093\/nar\/gki477.","journal-title":"Nucleic Acids Res"},{"issue":"42","key":"44_CR28","doi-asserted-by":"crossref","first-page":"26344","DOI":"10.1016\/S0021-9258(18)47199-2","volume":"269","author":"Z Chen","year":"1994","unstructured":"Chen Z, Li Y, Chen E, Hall DL, Darke PL, Culberson C, et al. Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases. J Biol Chem. 1994;269(42):26344\u20138.","journal-title":"J Biol Chem"},{"issue":"7","key":"44_CR29","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0969-2126(96)00091-3","volume":"4","author":"Y Hsiou","year":"1996","unstructured":"Hsiou Y, Ding J, Das K, Clark Jr AD, Hughes SH, Arnold E. Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms. Structure. 1996;4(7):853\u201360.","journal-title":"Structure"},{"issue":"5","key":"44_CR30","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1371\/journal.pcbi.0030087","volume":"3","author":"SY Rhee","year":"2007","unstructured":"Rhee SY, Liu TF, Holmes SP, Shafer RW. HIV-1 subtype B protease and reverse transcriptase amino acid covariation. PLoS Comput Biol. 2007;3(5):e87. doi:10.1371\/journal.pcbi.0030087.","journal-title":"PLoS Comput Biol"},{"issue":"9","key":"44_CR31","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/bioinformatics\/bti315","volume":"21","author":"AT Laurie","year":"2005","unstructured":"Laurie AT, Jackson RM. Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics. 2005;21(9):1908\u201316. doi:10.1093\/bioinformatics\/bti315.","journal-title":"Bioinformatics"},{"issue":"4","key":"44_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1073\/pnas.0508452103","volume":"103","author":"V Hornak","year":"2006","unstructured":"Hornak V, Okur A, Rizzo RC, Simmerling C. HIV-1 protease flaps spontaneously open and reclose in molecular dynamics simulations. Proc Natl Acad Sci U S A. 2006;103(4):915\u201320. doi:10.1073\/pnas.0508452103.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"44_CR33","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/prot.24151","volume":"80","author":"AS Braz","year":"2012","unstructured":"Braz AS, Tufanetto P, Perahia D, Scott LP. Relation between flexibility and positively selected HIV-1 protease mutants against inhibitors. Proteins. 2012;80(12):2680\u201391. 10.1002\/prot.24151.","journal-title":"Proteins"},{"key":"44_CR34","doi-asserted-by":"publisher","first-page":"D376","DOI":"10.1093\/nar\/gkl779","volume":"35(Database iss","author":"S Chang","year":"2007","unstructured":"Chang S, Zhang J, Liao X, Zhu X, Wang D, Zhu J, et al. Influenza Virus Database (IVDB): an integrated information resource and analysis platform for influenza virus research. Nucleic Acids Res. 2007;35(Database issue):D376\u201380. doi:10.1093\/nar\/gkl779.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"44_CR35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","volume":"2","author":"AL Totura","year":"2012","unstructured":"Totura AL, Baric RS. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol. 2012;2(3):264\u201375. doi:10.1016\/j.coviro.2012.04.004.","journal-title":"Curr Opin Virol"},{"issue":"3","key":"44_CR36","first-page":"272","volume":"9","author":"C Combet","year":"2009","unstructured":"Combet C, Bettler E, Terreux R, Garnier N, Deleage G. The euHCVdb suite of in silico tools for investigating the structural impact of mutations in hepatitis C virus proteins. Infect Disord: Drug Targets. 2009;9(3):272\u20138.","journal-title":"Infect Disord: Drug Targets"},{"issue":"7","key":"44_CR37","doi-asserted-by":"publisher","first-page":"e1001005","DOI":"10.1371\/journal.ppat.1001005","volume":"6","author":"AS Lauring","year":"2010","unstructured":"Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog. 2010;6(7):e1001005. 10.1371\/journal.ppat.1001005.","journal-title":"PLoS Pathog"},{"issue":"2","key":"44_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000331998","volume":"55","author":"MW Tang","year":"2012","unstructured":"Tang MW, Liu TF, Shafer RW. The HIVdb system for HIV-1 genotypic resistance interpretation. Intervirology. 2012;55(2):98\u2013101. 10.1159\/000331998.","journal-title":"Intervirology"},{"issue":"3","key":"44_CR39","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/genetics\/120.3.849","volume":"120","author":"RC Lewontin","year":"1988","unstructured":"Lewontin RC. On measures of gametic disequilibrium. Genetics. 1988;120(3):849\u201352.","journal-title":"Genetics"},{"issue":"1","key":"44_CR40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/genetics\/49.1.49","volume":"49","author":"RC Lewontin","year":"1964","unstructured":"Lewontin RC. The Interaction of Selection and Linkage. I. General Considerations; Heterotic Models. Genetics. 1964;49(1):49\u201367.","journal-title":"Genetics"},{"key":"44_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/BF01245622","volume":"6","author":"WG Hill","year":"1968","unstructured":"Hill WG, Roberston A. Linkage disequilibrium in finite populations. Theoritical and Applied Genetics. 1968;6:226\u201331.","journal-title":"Theoritical and Applied Genetics"},{"issue":"5","key":"44_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/protein\/gzi029","volume":"18","author":"O Noivirt","year":"2005","unstructured":"Noivirt O, Eisenstein M, Horovitz A. Detection and reduction of evolutionary noise in correlated mutation analysis. Protein Eng, Des Sel. 2005;18(5):247\u201353. doi:10.1093\/protein\/gzi029.","journal-title":"Protein Eng, Des Sel"},{"key":"44_CR43","unstructured":"The PyMOL Molecular Graphics System, Version 1.5.0.4 Schr\u00f6dinger, LLC. 2010."}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-015-0044-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13062-015-0044-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-015-0044-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-015-0044-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:46:44Z","timestamp":1630579604000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-015-0044-y"}},"subtitle":["Running title: Preventing HIV resistance"],"short-title":[],"issued":{"date-parts":[[2015,4,17]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1186\/s13062-015-0044-y","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,17]]},"assertion":[{"value":"19 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"17"}}